Gilead Sciences As of November 25, 2022 ticker dps (an.) 2022 hike 2021 hike 2020 hike
GILD $2.92 2.8% 4.4% 7.9%
Business yield Hike yrs 5 yr CAGR freq. paid since
Biotechnology 3.4% 7 7.0% Quarter 2015

Gilead Sciences (GILD) will raise its quarterly dividend by 2.8 percent to $0.73 per share in 2022. The biopharmaceutical company has now raised its dividend for the 7th consecutive year.

This post will be updated later.

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines. The company's principal areas of focus include human immunodeficiency virus (HIV), liver diseases (hepatitis C and hepatitis B), cardiovascular, hematology/oncology and inflammation/respiratory. Gilead became a public company in 1992 and has been paying a dividend since 2015. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

Dividend Calendar

Look at the complete list of upcoming events
Ex-date Ticker Yield YTD hike
Dec 05 ROST 1.1% 8.8%
Dec 05 CI 1.2% 0.0%
Dec 06 AVY 1.4% 0.0%
Dec 06 ODFL 0.4% 50.0%
Dec 06 BLK 2.6% 18.2%
Dec 06 AEE 2.7% 7.3%
Dec 06 AME 0.6% 10.0%
Dec 06 SLB 1.4% 40.0%
Dec 07 HAL 1.3% 166.7%
Dec 07 NEM 4.8% 0.0%